Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 99 publications
Targeting TROP2 Across Solid Tumors: The Clinical Profile and Role of Datopotamab Deruxtecan.
Journal: The Annals of pharmacotherapy
Published: December 01, 2025
Datopotamab deruxtecan versus docetaxel for non-small cell lung cancer: a plain language summary of the TROPION-Lung01 study.
Journal: Future oncology (London, England)
Published: November 21, 2025
Antibody-Based Therapeutics in Breast Cancer: Clinical and Translational Perspectives.
Journal: Antibodies (Basel, Switzerland)
Published: October 30, 2025
TROP-2-directed antibody-drug conjugates in advanced NSCLC: A systematic review and meta-analysis of efficacy, safety, and reconstructed survival outcomes.
Journal: Critical reviews in oncology/hematology
Published: October 27, 2025
Intracranial activity of antibody-drug conjugates in advanced non-small cell lung cancer: What have we accomplished so far?
Journal: Cancer treatment reviews
Published: October 26, 2025
Targeting common EGFR mutations in NSCLC-review of global phase III trials of third-generation inhibitors.
Journal: Journal of the National Cancer Institute
Published: October 24, 2025
Efficacy and Safety of Antibody Drug Conjugates in Previously Treated Hormone Receptor Positive HER2 Negative (or Low) Metastatic Breast Cancer-A Systematic Review and Meta-Analysis.
Journal: American journal of clinical oncology
Published: October 14, 2025
Cost-effectiveness analysis of datopotamab deruxtecan versus docetaxel for previously treated advanced or metastatic non-small cell lung cancer.
Journal: Cost effectiveness and resource allocation : C/E
Published: October 11, 2025
Antibody-drug conjugates in the treatment of advanced triple-negative breast cancer.
Journal: Przeglad menopauzalny = Menopause review
Published: August 24, 2025
An overview of recent advancements in targeted cancer therapies and their potential clinical impact.
An overview of recent advancements in targeted cancer therapies and their potential clinical impact.
Journal: RSC medicinal chemistry
Published: August 23, 2025
Datopotamab deruxtecan: rational strategies, novel advancements, challenges, and future perspectives.
Journal: Cancer treatment reviews
Published: August 21, 2025
Antibody-drug conjugates in breast cancer: From therapeutic and immune activation mechanisms to resistance prevention.
Journal: International reviews of immunology
Published: August 19, 2025
Last Updated: 02/24/2026